This site is intended for healthcare professionals
Journals
  • Home
  • /
  • Journals
  • /
  • Leukaemia
  • /
  • Role of microRNAs in chronic lymphocytic leukemia ...
Journal

Role of microRNAs in chronic lymphocytic leukemia pathogenesis.

Read time: 1 mins
Published:11th Sep 2019
Author: Javandoost E, Majd EF, Rostamian H, Koosheh MK, Mirzaei HR.
Availability: Pay for access, or by subscription
Ref.:Curr Med Chem. 2019.
DOI:10.2174/0929867326666190911114842

MicroRNAs (miRNAs) are a group of small endogenous non-coding RNAs involved in many cancers and various cellular processes such as cellular growth, DNA methylation, apoptosis, and differentiation. 13q14.3 chromosomal region contains miR-15 and miR-16 and deletion of this region is a commonly reported aberration in chronic lymphoblastic leukemia (CLL), suggesting miRNAs involvement in CLL pathogenesis. MicroRNAs are known oncogenes and tumor suppressors in CLL which may also serve as markers of onset and progression of the disease. The most prevalent form of leukemia diagnosed in adults in the western world, chronic lymphocytic leukemia, accounts for one-third of all leukemias. CLL is characterized by presence of B cell malignant clones in secondary lymphoid tissues, peripheral blood and bone marrow. The precise etiology of CLL is remained to be known, however, a number of chromosomal abnormalities such as deletions of 13q14.3, 11q and 17p and trisomy 12 have been detected. In this review, we offer our prospect on how miRNAs are involved in the CLL pathogenesis and disease progression. Further understanding of the underlying mechanisms and regulation of CLL pathogenesis has underscored the need for further research regarding their role in this disease.

 

Read abstract on library site

Access full article